Allergy

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education
American College of Allergy, Asthma & Immunology Annual Scientific Meeting

FDA Alerts

FDA Alert
phone that says FDA
FDA Alert
FDA Approves Dupilumab for Allergic Fungal Rhinosinusitis
02/25/2026
Kate Young
The FDA has approved dupilumab (Dupixent) for the treatment of allergic fungal rhinosinusitis, a rare form of chronic sinus inflammation driven by hypersensitivity to fungal organisms in the sinuses, in...
02/25/2026
FDA Alert
shutterstock
FDA Alert
FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis
08/19/2024
Anthony Calabro, MA
The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.
08/19/2024
allergy
allergy
FDA Approves New Option for Chronic Rhinosinusitis With Nasal Polyps
06/26/2019
The FDA has approved the first treatment option for chronic, inadequately controlled rhinosinusitis with nasal polyps.
06/26/2019